Recent studies have reported significant results using a new class of immune boosting drugs to fight cancer. So, far results show that not every type of cancer is effected in the same way, with the most substantial results being with the treatment of melanoma and lung cancer. See more here. (Source: Andrew Pollack, The New York Times, 5/29/15)